Director, Medical Affairs
Illumina$180,000 - $220,000/year
Full Time
Mid-level (3 to 4 years), Senior (5 to 8 years)
[Remote] Senior Director, Field Medical Affairs at Amylyx Pharmaceuticals
Cambridge, Massachusetts, United States
Not SpecifiedCompensation
N/AExperience Level
N/AJob Type
Not SpecifiedVisa
N/AIndustries
Requirements
- Advanced degree (PharmD, MD, PhD, or equivalent)
- Minimum 10 years of relevant experience in the pharmaceutical or biotech industry
- Minimum 5 years in a field medical leadership role with people management responsibilities
- Strong understanding of drug development, clinical trial methodology, and industry regulations and guidelines
- Experience/expertise in endocrinology/obesity medicine strongly preferred
Responsibilities
- Develop and execute the national field medical strategy
- Recruit, hire, train, and manage a high-performing field medical team
- Oversee the team's scientific exchange activities with external stakeholders
- Partner with internal departments to ensure alignment and support for strategic initiatives
- Establish a process for gathering, summarizing, and disseminating field-based medical insights
- Ensure all field medical activities adhere to company SOPs and regulatory guidelines
- Oversee operational aspects, including budget management and performance tracking
Skills
Amylyx Pharmaceuticals
Develops treatments for neurodegenerative diseases
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, focusing on conditions like Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (ALZ). Their main product, AMX0035, is currently undergoing clinical trials to assess its effectiveness. The CENTAUR ALS trial showed promising results for ALS patients, using a randomized, double-blind, placebo-controlled design to ensure reliable outcomes. They are also conducting the PEGASUS trial to evaluate AMX0035's safety and effectiveness in Alzheimer's patients. Unlike many competitors, Amylyx emphasizes community engagement and awareness campaigns, such as ALS Awareness Month, to educate the public and foster support for those affected by these diseases. The company's goal is to bring effective therapies to market that improve patient outcomes and enhance the quality of life for individuals suffering from neurodegenerative conditions.
Cambridge, MassachusettsHeadquarters
2013Year Founded
$166.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees